Refresh

Fresenius Kabi Oncology Ltd. - Research Center

532545 FKONCO Group (B) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10 Mar ' 09

Sales

596.30 524.32 412.37 421.48 286.29

Operating profit

143.00 67.45 95.98 96.64 -29.29

Interest

-2.60 13.07 18.03 19.40 21.97

Gross profit

147.40 55.77 84.24 83.38 -51.26

EPS (Rs)

5.09 3.22 3.11 5.07 -4.91
Annual  results in details
Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10 Mar ' 09

Other income

1.80 1.39 6.29 6.13 -

Stock adjustment

-31.02 6.02 7.05 -30.13 -26.35

Raw material

191.74 206.05 125.28 144.77 91.73

Power and fuel

- - - - -

Employee expenses

70.32 60.98 56.11 47.59 44.51

Excise

- - - - 11.15

Admin and selling expenses

- - - - -

Research and development expenses

95.03 65.69 45.47 34.70 30.73

Expenses capitalised

- - - - -

Other expenses

127.23 118.12 82.49 127.90 163.81

Provisions made

- - - - -

Depreciation

25.79 23.97 16.92 12.51 11.81

Taxation

34.22 13.36 20.76 5.87 2.78

Net profit / loss

80.59 50.95 49.24 80.23 -77.70

Extra ordinary item

-6.81 32.52 2.68 15.23 -11.84

Prior year adjustments

- - - - -

Equity capital

15.82 15.82 15.82 15.82 15.82

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

300.63 158.23 158.23 158.23 -

Agg.of non promotoholding (%)

19.00 10.00 10.00 10.00 -

OPM (%)

23.98 12.87 23.28 22.93 -10.23

GPM (%)

24.65 10.61 20.12 19.50 -

NPM (%)

13.47 9.69 11.76 18.76 -
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com